scholarly article | Q13442814 |
P2093 | author name string | Guang Sun | |
Henri C van der Heyde | |||
Catherine Woods | |||
Irene Gramaglia | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Plasmodium berghei | Q65021 |
P304 | page(s) | 1956-1963 | |
P577 | publication date | 2004-10-19 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines | |
P478 | volume | 105 |
Q27347602 | Absence of apolipoprotein E protects mice from cerebral malaria |
Q30478897 | Biomimetic amplification of nanoparticle homing to tumors |
Q47859177 | CD41 is a reliable identification and activation marker for murine basophils in the steady state and during helminth and malarial infections |
Q58754437 | Cerebral Malaria in Mouse and Man |
Q21032533 | Cerebral malaria: mysteries at the blood-brain barrier |
Q64117827 | Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak |
Q30482595 | Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities |
Q37162381 | Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding |
Q38310270 | Emerging evidence for platelets as immune and inflammatory effector cells |
Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
Q27322655 | Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier |
Q30561036 | Imaging Plasmodium immunobiology in the liver, brain, and lung |
Q34447833 | Immunological processes in malaria pathogenesis. |
Q37139922 | Integrin αDβ2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS). |
Q45997398 | Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. |
Q27318431 | Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host |
Q35213593 | Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection |
Q37016412 | Platelet factor 4 mediates inflammation in experimental cerebral malaria |
Q33573493 | Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria |
Q40020303 | Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria |
Q33422357 | Platelet interactions with viruses and parasites |
Q24612640 | Platelet power: sticky problems for sticky parasites? |
Q92351178 | Platelet α-granules contribute to organ-specific pathologies in a mouse model of severe malaria |
Q33438503 | Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response |
Q39580141 | Platelets as pathogenetic effectors and killer cells in cerebral malaria. |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q39027765 | Platelets in infectious disease. |
Q36084093 | Platelets present antigen in the context of MHC class I. |
Q37395743 | Platelets: essential components of the immune system |
Q37240446 | Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes |
Q36446215 | Protection against cerebral malaria by the low-molecular-weight thiol pantethine |
Q37527691 | Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice |
Q38666558 | The immunological balance between host and parasite in malaria |
Q33387926 | The role of platelets in the pathogenesis of cerebral malaria |
Search more.